Skip to content

The VA-STRIDE Study

Expert System-Based Feedback in Sedentary Overweight Veterans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00731094
Enrollment
232
Registered
2008-08-08
Start date
2010-06-30
Completion date
2013-05-31
Last updated
2015-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight, Sedentary Lifestyle

Keywords

overweight, sedentary lifestyle, exercise, primary health care, controlled clinical trials, randomized

Brief summary

The purpose of the study was to examine the effectiveness of an expert-system, print-based physical activity (PA) intervention delivered to Veterans receiving primary care at the VA Pittsburgh Healthcare System (VAPHS).

Detailed description

A.1 The primary aim of the study was to determine the effect of a physical activity intervention designed to increase physical activity for sedentary Veterans at VAPHS. A.2. Secondary aims were to assess key health-related outcomes related to the intervention including health and quality of life. The specific outcomes were to (a) estimate the impact of the intervention on physical function, health-related quality of life (HRQL), weight, blood pressure, and serum lipids; and (b) characterize variation in intervention effectiveness by participant sociodemographic and health characteristics, such as age, race, and baseline health status. 232 Veterans were randomized to either the physical activity intervention group or the attention control group. Participants randomized to the physical activity intervention group participated in an individualized physical activity counseling session at baseline, conducted by an exercise physiologist, with guided goal setting to increase physical activity gradually to at least 150 minutes/week of moderate intensity. An additional 14 intervention counseling contacts, generated by participants' responses to physical activity questionnaires and individually tailored computer-generated expert system feedback messages based on stages of the motivational readiness for change model, were conducted via postal mail over the subsequent 12 months in parallel with routine primary care. Newsletters providing additional support and suggestions for increasing physical activity were also part of the mailed counseling contacts. Participants randomized to the attention control group participated in a generalized healthy lifestyle counseling session at baseline, conducted by a health educator, which included limited advice to become more physically active. Fourteen follow-up wellness newsletters that focused on healthy lifestyle issues other than physical activity were sent to participants via postal mail over the subsequent 12 months with the same frequency of contact as for the physical activity intervention group and in parallel with routine primary care. Assessment of effectiveness occurred at baseline, 6, and 12 months.

Interventions

BEHAVIORALExpert system-based physical activity counseling

The intervention included 14 mailings to participants that involved completion of physical activity questionnaires printed on forms that were scanned into a computerized expert system program to generate individually-tailored feedback messages and related manuals based on the Stages of Motivational Readiness for Change Model. Newsletters providing additional support and suggestions for increasing physical activity were also part of the mailing program.

Sponsors

Brown University
CollaboratorOTHER
University of Pittsburgh
CollaboratorOTHER
US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* at least 18 years of age at the time of enrollment, * one or more primary care clinic visits at VAPHS in the 12 months prior to enrollment * overweight or obese, with a BMI \> =25.0 kg/m\^2 at the most recent primary care visit prior to enrollment.

Exclusion criteria

* primary care provider judgment that unsupervised moderate-intensity exercise will place the Veteran at risk of a cardiovascular event, or other safety concern for guided but unsupervised physical activity * Veteran is nonambulatory or requires assistive devices to ambulate (e.g., wheelchairs, prosthetic legs, canes or walkers), * Veteran regularly participates in moderate to brisk physical activity 60 minutes or more each week * current diagnosis of pulmonary hypertension, chronic obstructive pulmonary disease (COPD), and other comorbid conditions deemed to be contraindications for guided, unsupervised physical activity * self-reported blindness and/or unable to read printed material in English (e.g., a newspaper) * plans to move from the VAPHS treatment area in the next 12 months * unable or unwilling to travel to the study site 4 times during the 12-month study period * VAPHS employee * current participant in another interventional research study that may confound outcomes * unable or unwilling to provide signed, informed consent

Design outcomes

Primary

MeasureTime frameDescription
Moderate Intensity Physical Activity: Modified Community Healthy Activities Model Program for Seniors (CHAMPS) QuestionnaireMonth 0Participants achieving 150 minutes/week of moderate intensity or greater physical activity at Month 0 as measured with the modified CHAMPS Questionnaire
Moderate Intensity Physical Activity: Modified CHAMPS QuestionnaireMonth 6Participants achieving 150 minutes/week of moderate intensity or greater physical activity at Month 6 as measured with the modified CHAMPS Questionnaire
Moderate Intensity Physical Activity: AccelerometerMonth 0Participants with an average of at least 30 minutes/day of moderate intensity or greater physical activity in a subset of the study population for whom accelerometer data were obtained: 97 of 116 in Physical Activity Intervention Group and 103 of 116 in Attention Control Group at Month 0

Secondary

MeasureTime frameDescription
Diastolic BPMonth 0Diastolic BP measured at Month 0
Low-density Lipoprotein (LDL) CholesterolMonth 0LDL cholesterol in milligrams per deciliter (mg/dL) measured at Month 0
LDL CholesterolMonth 6LDL cholesterol measured at Month 6
High-density Lipoprotein (HDL) CholesterolMonth 0HDL cholesterol in milligrams/deciliter (mg/dL) measured at Month 0
HDL CholesterolMonth 6HDL cholesterol measured at Month 6
TriglyceridesMonth 0Triglycerides measured at Month 0
WeightMonth 0Weight in kilograms (kg) measured at Month 0
HRQL: SF-36 PCSMonth 6HRQL: SF-36 PCS measured at Month 6. The SF-36 is a multi-purpose, short-form health survey with 36 questions. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. The 8 scales are the weighted sums of the 2-10 questions in their section. Norm-based scoring, where each scale and component summary measures were scored to have the same average (50) and the same standard deviation (10 points), was used for reporting results in this study. Scores are interpreted as the lower the score the more disability; conversely, the higher the score the less disability. The PCS aggregates the scales for bodily pain, general health perceptions, physical functioning, and role limitation due to physical health problems.
HRQL: SF-36 Mental Component Summary Measure (MSC)Month 0HRQL: SF-36 MCS measured at Month 0. The SF-36 is a multi-purpose, short-form health survey with 36 questions. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. The 8 scales are the weighted sums of the 2-10 questions in their section. Norm-based scoring, where each scale and component summary measures were scored to have the same average (50) and the same standard deviation (10 points), was used for reporting results in this study. Scores are interpreted as the lower the score the more disability; conversely, the higher the score the less disability. The MCS aggregates the scales for vitality, mental health, social functioning, and role limitations due to personal or emotional problems.
HRQL: SF-36 MCSMonth 6HRQL: SF-36 MCS measured at Month 6. The SF-36 is a multi-purpose, short-form health survey with 36 questions. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. The 8 scales are the weighted sums of the 2-10 questions in their section. Norm-based scoring, where each scale and component summary measures were scored to have the same average (50) and the same standard deviation (10 points), was used for reporting results in this study. Scores are interpreted as the lower the score the more disability; conversely, the higher the score the less disability. The MCS aggregates the scales for vitality, mental health, social functioning, and role limitations due to personal or emotional problems.
Physical Function: 6-Minute Walking Distance (6MWD)Month 0Physical Function: 6MWD in meters measured at Month 0
Physical Function: 6MWDMonth 6Physical Function: 6MWD measured at Month 6
Health Related Quality of Life (HRQL): Short Form 36 Health Survey Questionnaire (SF-36) Physical Component Summary Measure (PCS)Month 0HRQL: SF-36 PCS measured at Month 0. The SF-36 is a multi-purpose, short-form health survey with 36 questions. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. The 8 scales are the weighted sums of the 2-10 questions in their section. Norm-based scoring, where each scale and component summary measures were scored to have the same average (50) and the same standard deviation (10 points), was used for reporting results in this study. Scores are interpreted as the lower the score the more disability; conversely, the higher the score the less disability. The PCS aggregates the scales for bodily pain, general health perceptions, physical functioning, and role limitation due to physical health problems.
Systolic Blood Pressure (BP)Month 0Systolic BP in millimeters of mercury (mmHg) measured at Month 0
Systolic BPMonth 6Systolic BP measured at Month 6

Countries

United States

Participant flow

Participants by arm

ArmCount
Physcial Activity Intervention
Individualized baseline counseling and guided goal setting to increase physical activity gradually to at least 150 minutes/week of moderate intensity, with a 12-month follow-up via postal mail of 14 additional counseling contacts generated by responses to a physical activity questionnaire and individually tailored computer-generated expert system feedback messages for physical activity based on stages of the motivational readiness for change model
116
Attention Control
Generalized baseline healthy lifestyle education and suggestion to increase physical activity, with a 12-month follow-up via postal mail of 14 wellness newsletters focused on health issues other than physical activity
116
Total232

Baseline characteristics

CharacteristicPhyscial Activity InterventionAttention ControlTotal
Age, Continuous63.7 years
STANDARD_DEVIATION 12.5
62.6 years
STANDARD_DEVIATION 13.2
63.2 years
STANDARD_DEVIATION 12.8
Body Mass Index (BMI)31.1 kg/m2
STANDARD_DEVIATION 4.7
32.2 kg/m2
STANDARD_DEVIATION 5
31.6 kg/m2
STANDARD_DEVIATION 4.9
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants3 Participants7 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
111 Participants113 Participants224 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
28 Participants26 Participants54 Participants
Race (NIH/OMB)
More than one race
1 Participants2 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants2 Participants
Race (NIH/OMB)
White
86 Participants87 Participants173 Participants
Region of Enrollment
United States
116 participants116 participants232 participants
Sex: Female, Male
Female
20 Participants20 Participants40 Participants
Sex: Female, Male
Male
96 Participants96 Participants192 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1160 / 116
serious
Total, serious adverse events
29 / 11633 / 116

Outcome results

Primary

Moderate Intensity Physical Activity: Accelerometer

Participants with an average of at least 30 minutes/day of moderate intensity or greater physical activity in a subset of the study population for whom accelerometer data were obtained: 77 of 101 in Physical Activity Intervention Group and 76 of 107 in Attention Control Group in Month 6

Time frame: Month 6

ArmMeasureValue (NUMBER)
Physical Activity InterventionModerate Intensity Physical Activity: Accelerometer26 participants
Attention ControlModerate Intensity Physical Activity: Accelerometer19 participants
Primary

Moderate Intensity Physical Activity: Accelerometer

Participants with an average of at least 30 minutes/day of moderate intensity or greater physical activity in a subset of the study population for whom accelerometer data were obtained: 97 of 116 in Physical Activity Intervention Group and 103 of 116 in Attention Control Group at Month 0

Time frame: Month 0

ArmMeasureValue (NUMBER)
Physical Activity InterventionModerate Intensity Physical Activity: Accelerometer31 participants
Attention ControlModerate Intensity Physical Activity: Accelerometer36 participants
Primary

Moderate Intensity Physical Activity: Accelerometer

Participants with an average of at least 30 minutes/day of moderate intensity or greater physical activity in a subset of the study population for whom accelerometer data were obtained: 71 of 98 in Physical Activity Intervention Group and 74 of 105 in Attention Control Group at Month 12

Time frame: Month 12

ArmMeasureValue (NUMBER)
Physical Activity InterventionModerate Intensity Physical Activity: Accelerometer24 participants
Attention ControlModerate Intensity Physical Activity: Accelerometer21 participants
Primary

Moderate Intensity Physical Activity: Modified CHAMPS Questionnaire

Participants achieving 150 minutes/week of moderate intensity or greater physical activity at Month 6 as measured with the modified CHAMPS Questionnaire

Time frame: Month 6

ArmMeasureValue (NUMBER)
Physical Activity InterventionModerate Intensity Physical Activity: Modified CHAMPS Questionnaire48 participants
Attention ControlModerate Intensity Physical Activity: Modified CHAMPS Questionnaire53 participants
Primary

Moderate Intensity Physical Activity: Modified CHAMPS Questionnaire

Participants achieving 150 minutes/week of moderate intensity or greater physical activity at Month 12 as measured with the modified CHAMPS Questionnaire

Time frame: Month 12

ArmMeasureValue (NUMBER)
Physical Activity InterventionModerate Intensity Physical Activity: Modified CHAMPS Questionnaire52 participants
Attention ControlModerate Intensity Physical Activity: Modified CHAMPS Questionnaire49 participants
Primary

Moderate Intensity Physical Activity: Modified Community Healthy Activities Model Program for Seniors (CHAMPS) Questionnaire

Participants achieving 150 minutes/week of moderate intensity or greater physical activity at Month 0 as measured with the modified CHAMPS Questionnaire

Time frame: Month 0

ArmMeasureValue (NUMBER)
Physical Activity InterventionModerate Intensity Physical Activity: Modified Community Healthy Activities Model Program for Seniors (CHAMPS) Questionnaire37 participants
Attention ControlModerate Intensity Physical Activity: Modified Community Healthy Activities Model Program for Seniors (CHAMPS) Questionnaire44 participants
Secondary

Diastolic BP

Diastolic BP measured at Month 12

Time frame: Month 12

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionDiastolic BP74.4 mmHgStandard Deviation 10.3
Attention ControlDiastolic BP75.9 mmHgStandard Deviation 9.9
Secondary

Diastolic BP

Diastolic BP measured at Month 6

Time frame: Month 6

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionDiastolic BP73.7 mmHgStandard Deviation 10.8
Attention ControlDiastolic BP75.7 mmHgStandard Deviation 10
Secondary

Diastolic BP

Diastolic BP measured at Month 0

Time frame: Month 0

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionDiastolic BP73.1 mmHgStandard Deviation 9.7
Attention ControlDiastolic BP74.1 mmHgStandard Deviation 9.5
Secondary

HDL Cholesterol

HDL cholesterol measured at Month 12

Time frame: Month 12

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionHDL Cholesterol45.8 mg/dLStandard Deviation 13.4
Attention ControlHDL Cholesterol44.3 mg/dLStandard Deviation 11.3
Secondary

HDL Cholesterol

HDL cholesterol measured at Month 6

Time frame: Month 6

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionHDL Cholesterol46.0 mg/dLStandard Deviation 12.9
Attention ControlHDL Cholesterol44.4 mg/dLStandard Deviation 10.2
Secondary

Health Related Quality of Life (HRQL): Short Form 36 Health Survey Questionnaire (SF-36) Physical Component Summary Measure (PCS)

HRQL: SF-36 PCS measured at Month 0. The SF-36 is a multi-purpose, short-form health survey with 36 questions. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. The 8 scales are the weighted sums of the 2-10 questions in their section. Norm-based scoring, where each scale and component summary measures were scored to have the same average (50) and the same standard deviation (10 points), was used for reporting results in this study. Scores are interpreted as the lower the score the more disability; conversely, the higher the score the less disability. The PCS aggregates the scales for bodily pain, general health perceptions, physical functioning, and role limitation due to physical health problems.

Time frame: Month 0

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionHealth Related Quality of Life (HRQL): Short Form 36 Health Survey Questionnaire (SF-36) Physical Component Summary Measure (PCS)44.7 scores on a scaleStandard Deviation 8.3
Attention ControlHealth Related Quality of Life (HRQL): Short Form 36 Health Survey Questionnaire (SF-36) Physical Component Summary Measure (PCS)47.0 scores on a scaleStandard Deviation 8.3
Secondary

High-density Lipoprotein (HDL) Cholesterol

HDL cholesterol in milligrams/deciliter (mg/dL) measured at Month 0

Time frame: Month 0

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionHigh-density Lipoprotein (HDL) Cholesterol45.4 mg/dLStandard Deviation 12.6
Attention ControlHigh-density Lipoprotein (HDL) Cholesterol43.2 mg/dLStandard Deviation 11.1
Secondary

HRQL: SF-36 MCS

HRQL: SF-36 MCS measured at Month 12. The SF-36 is a multi-purpose, short-form health survey with 36 questions. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. The 8 scales are the weighted sums of the 2-10 questions in their section. Norm-based scoring, where each scale and component summary measures were scored to have the same average (50) and the same standard deviation (10 points), was used for reporting results in this study. Scores are interpreted as the lower the score the more disability; conversely, the higher the score the less disability. The MCS aggregates the scales for vitality, mental health, social functioning, and role limitations due to personal or emotional problems.

Time frame: Month 12

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionHRQL: SF-36 MCS53.0 scores on a scaleStandard Deviation 9.5
Attention ControlHRQL: SF-36 MCS52.8 scores on a scaleStandard Deviation 8.4
Secondary

HRQL: SF-36 MCS

HRQL: SF-36 MCS measured at Month 6. The SF-36 is a multi-purpose, short-form health survey with 36 questions. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. The 8 scales are the weighted sums of the 2-10 questions in their section. Norm-based scoring, where each scale and component summary measures were scored to have the same average (50) and the same standard deviation (10 points), was used for reporting results in this study. Scores are interpreted as the lower the score the more disability; conversely, the higher the score the less disability. The MCS aggregates the scales for vitality, mental health, social functioning, and role limitations due to personal or emotional problems.

Time frame: Month 6

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionHRQL: SF-36 MCS51.3 scores on a scaleStandard Deviation 10.8
Attention ControlHRQL: SF-36 MCS51.6 scores on a scaleStandard Deviation 9.4
Secondary

HRQL: SF-36 Mental Component Summary Measure (MSC)

HRQL: SF-36 MCS measured at Month 0. The SF-36 is a multi-purpose, short-form health survey with 36 questions. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. The 8 scales are the weighted sums of the 2-10 questions in their section. Norm-based scoring, where each scale and component summary measures were scored to have the same average (50) and the same standard deviation (10 points), was used for reporting results in this study. Scores are interpreted as the lower the score the more disability; conversely, the higher the score the less disability. The MCS aggregates the scales for vitality, mental health, social functioning, and role limitations due to personal or emotional problems.

Time frame: Month 0

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionHRQL: SF-36 Mental Component Summary Measure (MSC)51.6 scores on a scaleStandard Deviation 9.6
Attention ControlHRQL: SF-36 Mental Component Summary Measure (MSC)53.0 scores on a scaleStandard Deviation 8.6
Secondary

HRQL: SF-36 PCS

HRQL: SF-36 PCS measured at Month 12. The SF-36 is a multi-purpose, short-form health survey with 36 questions. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. The 8 scales are the weighted sums of the 2-10 questions in their section. Norm-based scoring, where each scale and component summary measures were scored to have the same average (50) and the same standard deviation (10 points), was used for reporting results in this study. Scores are interpreted as the lower the score the more disability; conversely, the higher the score the less disability. The PCS aggregates the scales for bodily pain, general health perceptions, physical functioning, and role limitation due to physical health problems.

Time frame: Month 12

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionHRQL: SF-36 PCS44.9 scores on a scaleStandard Deviation 9.3
Attention ControlHRQL: SF-36 PCS45.1 scores on a scaleStandard Deviation 9.5
Secondary

HRQL: SF-36 PCS

HRQL: SF-36 PCS measured at Month 6. The SF-36 is a multi-purpose, short-form health survey with 36 questions. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index. The 8 scales are the weighted sums of the 2-10 questions in their section. Norm-based scoring, where each scale and component summary measures were scored to have the same average (50) and the same standard deviation (10 points), was used for reporting results in this study. Scores are interpreted as the lower the score the more disability; conversely, the higher the score the less disability. The PCS aggregates the scales for bodily pain, general health perceptions, physical functioning, and role limitation due to physical health problems.

Time frame: Month 6

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionHRQL: SF-36 PCS45.4 scores on a scaleStandard Deviation 8.1
Attention ControlHRQL: SF-36 PCS45.4 scores on a scaleStandard Deviation 8.9
Secondary

LDL Cholesterol

LDL cholesterol measured at Month 12

Time frame: Month 12

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionLDL Cholesterol92.4 mg/dLStandard Deviation 31.9
Attention ControlLDL Cholesterol96.8 mg/dLStandard Deviation 39.2
Secondary

LDL Cholesterol

LDL cholesterol measured at Month 6

Time frame: Month 6

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionLDL Cholesterol91.6 mg/dLStandard Deviation 33.4
Attention ControlLDL Cholesterol95.8 mg/dLStandard Deviation 29.3
Secondary

Low-density Lipoprotein (LDL) Cholesterol

LDL cholesterol in milligrams per deciliter (mg/dL) measured at Month 0

Time frame: Month 0

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionLow-density Lipoprotein (LDL) Cholesterol95.3 mg/dLStandard Deviation 33.7
Attention ControlLow-density Lipoprotein (LDL) Cholesterol96.4 mg/dLStandard Deviation 33.1
Secondary

Physical Function: 6-Minute Walking Distance (6MWD)

Physical Function: 6MWD in meters measured at Month 0

Time frame: Month 0

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionPhysical Function: 6-Minute Walking Distance (6MWD)435.9 metersStandard Deviation 88.7
Attention ControlPhysical Function: 6-Minute Walking Distance (6MWD)445.5 metersStandard Deviation 100.3
Secondary

Physical Function: 6MWD

Physical Function: 6MWD measured at Month 12

Time frame: Month 12

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionPhysical Function: 6MWD457.5 metersStandard Deviation 81.4
Attention ControlPhysical Function: 6MWD444.9 metersStandard Deviation 127.2
Secondary

Physical Function: 6MWD

Physical Function: 6MWD measured at Month 6

Time frame: Month 6

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionPhysical Function: 6MWD453.9 metersStandard Deviation 79.8
Attention ControlPhysical Function: 6MWD458.5 metersStandard Deviation 105.9
Secondary

Systolic Blood Pressure (BP)

Systolic BP in millimeters of mercury (mmHg) measured at Month 0

Time frame: Month 0

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionSystolic Blood Pressure (BP)126.1 mmHgStandard Deviation 17.8
Attention ControlSystolic Blood Pressure (BP)126.1 mmHgStandard Deviation 14.2
Secondary

Systolic BP

Systolic BP measured at Month 6

Time frame: Month 6

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionSystolic BP129.1 mmHgStandard Deviation 17.8
Attention ControlSystolic BP130.1 mmHgStandard Deviation 16
Secondary

Systolic BP

Systolic BP measured at Month 12

Time frame: Month 12

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionSystolic BP130.0 mmHgStandard Deviation 18.3
Attention ControlSystolic BP129.3 mmHgStandard Deviation 16.9
Secondary

Triglycerides

Triglycerides measured at Month 12

Time frame: Month 12

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionTriglycerides145.8 mg/dLStandard Deviation 81.8
Attention ControlTriglycerides144.2 mg/dLStandard Deviation 95.4
Secondary

Triglycerides

Triglycerides measured at Month 6

Time frame: Month 6

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionTriglycerides128.5 mg/dLStandard Deviation 73.5
Attention ControlTriglycerides139.7 mg/dLStandard Deviation 88.1
Secondary

Triglycerides

Triglycerides measured at Month 0

Time frame: Month 0

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionTriglycerides132.9 mg/dLStandard Deviation 73.6
Attention ControlTriglycerides134.4 mg/dLStandard Deviation 87.4
Secondary

Weight

Weight in kilograms (kg) measured at Month 0

Time frame: Month 0

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionWeight95.5 kgStandard Deviation 16.9
Attention ControlWeight98.7 kgStandard Deviation 17.3
Secondary

Weight

Weight in kilograms measured at Month 12

Time frame: Month 12

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionWeight95.3 kgStandard Deviation 17.5
Attention ControlWeight98.0 kgStandard Deviation 17.4
Secondary

Weight

Weight in kilograms at measured at Month 6

Time frame: Month 6

ArmMeasureValue (MEAN)Dispersion
Physical Activity InterventionWeight95.2 kgStandard Deviation 17.5
Attention ControlWeight97.7 kgStandard Deviation 17.7

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026